NYSE : CON
$0.04 (0.12%)
27.75%
128
change: -152.0 | last: 28069
change: -75.0 | last: 14433
change: -62.0 | last: 9523
change: -27.0 | last: 50175
change: 143.0 | last: 32-
-
0.00
change: 0.0 | last: 01.04B
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-04-29 | Vanguard Portfolio Management | 6.84M | 5.32% |
| 2026-03-26 | The Vanguard Group | - | 0.00% |
| 2026-02-17 | T. Rowe Price Associates, Inc. | 16.84M | 13.10% |
| 2025-11-26 | ORTENZIO ROBERT A | 8.17M | 6.40% |
| 2025-11-14 | T. Rowe Price Investment Management, Inc. | 6.27M | 4.90% |
| 2025-11-14 | T. Rowe Price Associates, Inc. | 17.17M | 13.40% |
| 2025-07-07 | The Vanguard Group | 13.18M | 10.28% |
| 2025-05-14 | T. Rowe Price Associates, Inc. | 14.72M | 11.50% |
| 2025-04-21 | BlackRock, Inc. | 16.13M | 12.60% |
| 2025-03-04 | Robert A. Ortenzio | 8.25M | 6.40% |
| 2025-03-04 | Estate of Rocco A. Ortenzio | 3.3M | 2.57% |
| 2025-02-14 | T. Rowe Price Investment Management, Inc. | 8.61M | 6.80% |
| 2025-01-30 | The Vanguard Group | 12.32M | 9.67% |
| 2024-12-09 | 52-0556948 | 17.77M | 14.00% |
| 2024-12-09 | 52-0556948 | 17.77M | 14.00% |
| 2024-12-06 | (1) BlackRock, Inc. | 17.8M | 14.00% |
| 2024-12-03 | Robert A. Ortenzio | 7.22M | 5.70% |
| 2024-12-03 | Estate of Rocco A. Ortenzio | 6.37M | 5.00% |
| 2024-12-03 | Estate of Rocco A. Ortenzio | 6.37M | 5.00% |
| 2024-12-03 | Robert A. Ortenzio | 7.22M | 5.70% |
| 2024-09-05 | Select Medical Corporation | 104.09M | 81.70% |
| 2024-09-05 | Select Medical Corporation | 104.09M | 81.70% |
| 2015-03-30 | 23-2772200 | - | 0.00% |
| 2015-02-12 | 23-2772200 | 6.67M | 5.09% |
| 2015-02-12 | 23-2772200 | 6.67M | 5.09% |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $19.68 | 126.65M | $2.49B | $79.9M | $2.1B | $4.52B |
| 2024-12-31 | $19.78 | 128.13M | $2.53B | $183.26M | $1.95B | $4.3B |
| 2023-12-31 | $22.48 | 126.59M | $2.85B | $31.37M | $905M | $3.72B |
| 2022-12-31 | $22.48 | 126.59M | $2.85B | $37.66M | $1.04B | $3.85B |
| 2021-12-31 | $22.48 | 126.59M | $2.85B | -$ | -$ | $2.85B |
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29.75 | 126.65M | $3.77B | $158.04M | $2.14B | $5.75B |
| 2026-03-31 | $21.45 | 126.65M | $2.72B | $61.7M | $2.12B | $4.78B |
| 2025-12-31 | $19.68 | 126.65M | $2.49B | $79.9M | $2.1B | $4.52B |
| 2025-09-30 | $20.93 | 126.65M | $2.65B | $49.94M | $2.14B | $4.74B |
| 2025-06-30 | $20.57 | 126.65M | $2.61B | $73.87M | $2.18B | $4.71B |
| 2025-03-31 | $21.70 | 126.65M | $2.75B | $52.11M | $2.14B | $4.83B |
| 2024-12-31 | $19.78 | 128.13M | $2.53B | $183.26M | $1.95B | $4.3B |
| 2024-09-30 | $22.36 | 127.34M | $2.85B | $136.82M | $1.95B | $4.66B |
| 2024-06-30 | $22.48 | 126.59M | $2.85B | $50.67M | $860.98M | $3.66B |
| 2024-03-31 | $22.48 | 126.59M | $2.85B | $49.55M | $907.47M | $3.7B |
| 2023-12-31 | $22.48 | 126.59M | $2.85B | $31.37M | $905M | $3.72B |
| 2023-09-30 | $22.48 | 126.59M | $2.85B | -$ | -$ | $2.85B |